Cost-effectiveness analysis of docetaxel (Taxotere®) vs. 5-fluorouracil in combined therapy in the initial phases of breast cancer

被引：0

作者：

Miguel Martín-Jiménez

Álvaro Rodríguez-Lescure

Manuel Ruiz-Borrego

Miguel-Ángel Seguí-Palmer

Max Brosa-Riestra

机构：

[1] Hospital Universitario San Carlos,

[2] Hospital General Universitario,undefined

[3] Hospital Virgen del Rocío,undefined

[4] Corporación Sanitaria Parc Taulí,undefined

[5] Oblikue Consulting,undefined

[6] S.L.,undefined

来源：

Clinical and Translational Oncology | 2009年 / 11卷

关键词：

Breast cancer; Cost-effectiveness; Docetaxel;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 47 条

[41]

Hayman J.A.(undefined)undefined undefined undefined undefined-undefined

[42]

Solin L.J.(undefined)undefined undefined undefined undefined-undefined

[43]

Sacristán J.A.(undefined)undefined undefined undefined undefined-undefined

[44]

Oliva J.(undefined)undefined undefined undefined undefined-undefined

[45]

Del Llano J.(undefined)undefined undefined undefined undefined-undefined

[46]

Prieto L.(undefined)undefined undefined undefined undefined-undefined

[47]

Tengs T.O.(undefined)undefined undefined undefined undefined-undefined